A Phase 2 interventional study of CP-866,087 and CP-866,087 in Sexual Dysfunction, Physiological, sponsored by Pfizer. Completed at 12 sites in 5 countries. Open to female participants aged 20 Years to 45 Years. Per ClinicalTrials.gov, last updated 2010-11-01.
Sponsored by Pfizer · Phase 2, Interventional, and Treatment
CP-866,087 is a non-hormonal compound, acting on the central nervous system, which has been shown in animal models to restore sexual function.
115 studies on the registry are indexed under Sexual Dysfunction, Physiological; 46 are open to participants now.
This study's planned enrollment of 84 is above the median of 60 across 80 interventional studies indexed under Sexual Dysfunction, Physiological.
Browse Sexual Dysfunction, Physiological studies →Pfizer is the lead sponsor of 3,244 studies on the registry; 139 are open to participants now.
Of its 582 completed or terminated interventional studies of FDA-regulated products, 381 (65%) have results posted.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
Drug: CP-866,087
Drug: CP-866,087
Drug: CP-866,087
Drug: Placebo
Tablets for oral administration
Tablets for oral administration
Tablets for oral administration
Tablets for oral administration
Diary events, including Satisfactory Sexual Experiences (SSEs) over 6 weeks.
Time frame: 6 weeks
Score in Abbreviated Sexual Function Questionnaire after 6 weeks of treatment.
Time frame: 6 weeks
Exit interview at end of study. Meaningful Benefit Question at end of study.
Time frame: End of study
Measure of Female Sexual Distress questionnaire after 6 weeks of treatment.
Time frame: 6 weeks
This study is completed, as verified in Oct 2010. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Sexual Dysfunction, Physiological→
Pfizer